We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

225 hedge funds and large institutions have $609M invested in Editas Medicine in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 74 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $9.68M

27% more capital invested

Capital invested by funds: $481M → $609M (+$128M)

15% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 34

2% more funds holding

Funds holding: 220 → 225 (+5)

1.21% less ownership

Funds ownership: 74.77% → 73.56% (-1.2%)

28% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 74

Holders
225
Holders Change
+5
Holders Change %
+2.27%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
53
Reduced
74
Closed
34
Calls
$13.5M
Puts
$9.68M
Net Calls
+$3.87M
Net Calls Change
+$1.26M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10.5M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.06M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.07M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
+$4.88M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.7M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$20.8M
2
DTC
Deep Track Capital
Connecticut
-$14.3M
3
Marshall Wace
Marshall Wace
United Kingdom
-$9.51M
4
State Street
State Street
Massachusetts
-$6.16M
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$2.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
26
Rafferty Asset Management
New York
$4.14M -$1.34M -152,799 -27%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$3.88M +$3.37M +383,445 New
Bank of America
28
Bank of America
North Carolina
$3.77M +$382K +43,556 +13%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.17M -$8.53K -972 -0.3%
Jacobs Levy Equity Management
30
Jacobs Levy Equity Management
New Jersey
$2.89M +$1.77M +201,732 +243%
Barclays
31
Barclays
United Kingdom
$2.83M +$38.8K +4,421 +2%
SOMRS
32
State of Michigan Retirement System
Michigan
$2.77M – – –
RJA
33
Raymond James & Associates
Florida
$2.62M -$134K -15,244 -6%
TI
34
Trexquant Investment
Connecticut
$2.45M +$476K +54,245 +29%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$2.18M -$2.93M -334,059 -61%
CSS
36
Cubist Systematic Strategies
Connecticut
$2.15M +$1.86M +212,170 New
TCM
37
Tang Capital Management
California
$2.03M – – –
Mirae Asset Global Investments
38
Mirae Asset Global Investments
South Korea
$2.01M -$1.56M -177,556 -47%
SPS
39
Susquehanna Portfolio Strategies
Pennsylvania
$1.96M +$1.7M +193,188 New
Jane Street
40
Jane Street
New York
$1.68M +$854K +97,252 +141%
Stifel Financial
41
Stifel Financial
Missouri
$1.55M +$5.76K +656 +0.4%
Citigroup
42
Citigroup
New York
$1.52M -$549K -62,488 -29%
SEC
43
Seven Eight Capital
New York
$1.48M +$1.28M +146,345 New
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.47M -$302K -34,400 -19%
UBS Group
45
UBS Group
Switzerland
$1.46M +$309K +35,167 +32%
HF
46
HRT Financial
New York
$1.45M +$1.14M +130,049 +974%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.33M -$290 -33 -0%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
48
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.23M – – –
N
49
Natixis
France
$1.22M +$1.06M +120,609 New
PMEF
50
Point72 Middle East FZE
United Arab Emirates
$1.21M +$904K +103,003 +639%
1
2
3 4 5

EDIT Hedge Fund Activity: Q4 2023 in Review

225 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2023, worth a combined $609M — up 27% from $481M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new EDIT positions and 34 closed out — a net gain of 5 holders — while 53 added to existing stakes and 74 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $10.5M. The largest seller was Woodline Partners, cutting an estimated $20.8M.

  • 225 institutional investors held Editas Medicine (EDIT) as of Q4 2023, up from 220 in Q3 2023.
  • Funds reported $609M of Editas Medicine stock for Q4 2023, up 27% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q4 2023 and 34 closed out, a net change of +5 holders.
  • The largest Editas Medicine buyer in Q4 2023 was Morgan Stanley, an estimated $10.5M added.
  • The largest Editas Medicine seller in Q4 2023 was Woodline Partners, an estimated $20.8M sold.

Based on aggregated 13F filings for Q4 2023.